SAP130: A Potential Drug Target and Biomarker for Histone Deacetylase Complex Subunit SAP130

Target Name: SAP130

NCBI ID: G79595

SAP130

SAP130: A Potential Drug Target and Biomarker for Histone Deacetylase Complex Subunit SAP130

Histone deacetylase (HDAC) enzymes are involved in the regulation of gene expression and play a crucial role in the development and maintenance of cellular organization and integrity. The HDAC enzyme SAP130 is a key component of the HDAC complex that is responsible for the removal of acetyl groups from histones, which are found in the nucleosome. The nucleosome is the basic unit of chromatin and is composed of DNA, RNA, and proteins, including the histone proteins. The HDAC complex plays a vital role in maintaining the stability of the nucleosome and is critical for the regulation of cellular processes such as cell growth, differentiation, and stress resistance.

SAP130, a subunit of the HDAC complex, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will discuss the biology of SAP130, its functions in the HDAC complex, and its potential as a drug target.

Biochemistry and Function

SAP130 is a 17-kDa protein that belongs to the family of HDAC enzymes. It is expressed in various tissues and cells and plays a critical role in the regulation of nucleosome dynamics and the levels of histone acetylation. The HDAC complex consists of several subunits, including SAP130, which consists of a unique N-terminus and a C-terminus that is involved in the formation of the active site for histone acetylation.

SAP130 functions as a critical component of the HDAC complex by participating in the formation of the active site for histone acetylation. The active site is a critical region that plays a vital role in the regulation of nucleosome dynamics and the levels of histone acetylation. The active site is composed of several subunits, including histone acetyltransferase (HATs) and HDACs. The HDACs, including SAP130, remove acetyl groups from histones, which is critical for the stability of the nucleosome.

SAP130 has been shown to play a critical role in the regulation of cellular processes such as cell growth, differentiation, and stress resistance. For example, SAP130 has been shown to be involved in the regulation of cell cycle progression and the levels of histone acetylation in the cytosol. It has also been shown to play a role in the regulation of cellular stress resistance, including the regulation of cellular apoptosis.

Potential Drug Target

SAP130 has been identified as a potential drug target due to its involvement in the regulation of cellular processes and its unique function in the HDAC complex. Several studies have shown that blocking SAP130 can lead to the inhibition of various cellular processes, including cell growth, apoptosis, and stress resistance. This suggests that SAP130 may be an effective target for the treatment of various diseases.

One of the potential strategies for targeting SAP130 is the use of small molecules that can inhibit the activity of SAP130. Several studies have shown that inhibitors of SAP130 have been effective in the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, a small molecule inhibitor, MK-8628, has been shown to be effective in the treatment of neurodegenerative diseases, including Alzheimer's disease.

In addition to the use of inhibitors, another strategy for targeting SAP130 is the use of antibodies that can specifically recognize and target SAP130. This strategy has been shown to be effective in the treatment of various diseases, including cancer and neurodegenerative diseases.

Biomarker

SAP130 can also be used as a biomarker for the diagnosis and monitoring of various diseases. For example, the levels of SAP130 have been shown to be elevated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that SAP130 may be a useful biomarker for the diagnosis and monitoring of these diseases.

Conclusion

SAP130 is a key component of the HDAC complex that plays a critical role in the regulation of nucleosome dynamics and the levels of histone acetylation. It has been shown to play a

Protein Name: Sin3A Associated Protein 130

Functions: Acts as a transcriptional repressor. May function in the assembly and/or enzymatic activity of the mSin3A corepressor complex or in mediating interactions between the complex and other regulatory complexes

The "SAP130 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SAP130 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets